A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor)

Clinical trial NCT04435366 · COMPLETED

Trial details

NCT number: NCT04435366
Sponsor: IVERIC bio, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Geographic Atrophy Macular Degeneration

Start date: 2020-06-22
Primary completion: 2022-07-25
Enrollment: 448

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.